0.7908
price up icon3.93%   0.0299
pre-market  Pre-mercato:  .77   -0.0208   -2.63%
loading
Precedente Chiudi:
$0.7609
Aprire:
$0.76
Volume 24 ore:
475.04K
Relative Volume:
0.56
Capitalizzazione di mercato:
$20.57M
Reddito:
$7.10M
Utile/perdita netta:
$-31.59M
Rapporto P/E:
-0.303
EPS:
-2.61
Flusso di cassa netto:
$-26.75M
1 W Prestazione:
+0.74%
1M Prestazione:
-20.92%
6M Prestazione:
-46.57%
1 anno Prestazione:
-47.28%
Intervallo 1D:
Value
$0.757
$0.84
Intervallo di 1 settimana:
Value
$0.7299
$0.84
Portata 52W:
Value
$0.68
$2.88

Palatin Technologies Inc. Stock (PTN) Company Profile

Name
Nome
Palatin Technologies Inc.
Name
Telefono
609-495-2200
Name
Indirizzo
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Name
Dipendente
19
Name
Cinguettio
@PalatinTech
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
PTN's Discussions on Twitter

Confronta PTN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PTN
Palatin Technologies Inc.
0.7908 20.57M 7.10M -31.59M -26.75M -2.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
504.77 129.62B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
666.87 72.91B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
604.96 36.76B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.76 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
259.19 27.86B 3.32B -860.46M -1.04B -8.32

Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2015-06-05 Reiterato Canaccord Genuity Buy
2015-01-12 Reiterato ROTH Capital Buy
2012-05-23 Iniziato Noble Financial Buy
2007-01-23 Iniziato Next Generation Buy

Palatin Technologies Inc. Borsa (PTN) Ultime notizie

pulisher
Mar 13, 2025

Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

Mar 13, 2025
pulisher
Mar 11, 2025

Palatin Technologies (NYSEAMERICAN:PTN) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update - GuruFocus.com

Mar 09, 2025
pulisher
Feb 28, 2025

Palatin gears up for obesity treatment trials in 2025 - MSN

Feb 28, 2025
pulisher
Feb 24, 2025

Palatin Awaits Data Release From Phase 2 Trial Of Bremelanotide-Tirzepatide Combo In Weight Loss - RTTNews

Feb 24, 2025
pulisher
Feb 20, 2025

Palatin secures $4.7 million in stock and warrant sale By Investing.com - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 16, 2025

HC Wainwright Cuts Palatin Technologies (NYSEAMERICAN:PTN) Price Target to $7.00 - Armenian Reporter

Feb 16, 2025
pulisher
Feb 15, 2025

HC Wainwright Issues Pessimistic Forecast for Palatin Technologies (NYSEAMERICAN:PTN) Stock Price - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Palatin Technologies, Inc. (AMEX:PTN) Q2 2025 Earnings Call Transcript - Insider Monkey

Feb 14, 2025
pulisher
Feb 14, 2025

Palatin Technologies Inc (PTN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Feb 14, 2025
pulisher
Feb 13, 2025

Palatin Technologies Reports Q2 2025 Financial Results - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Earnings call transcript: Palatin Technologies Q2 FY2025 sees stock surge By Investing.com - Investing.com Nigeria

Feb 13, 2025
pulisher
Feb 13, 2025

Palatin’s Earnings Call: Mixed Results and Strategic Moves - TipRanks

Feb 13, 2025
pulisher
Feb 13, 2025

Earnings call transcript: Palatin Technologies Q2 FY2025 sees stock surge - Investing.com

Feb 13, 2025
pulisher
Feb 13, 2025

Palatin Technologies Q2 25 Earnings Conference Call At 11:00 AM ET - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Palatin Technologies Inc. Q2 Loss Decreases, Beats Estimates - Nasdaq

Feb 13, 2025
pulisher
Feb 13, 2025

Palatin Slashes Quarterly Losses 70%, Obesity Drug Trial Results Imminent - StockTitan

Feb 13, 2025
pulisher
Feb 11, 2025

Palatin secures $4.7 million in stock and warrant sale - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Palatin Technologies (PTN) Expected to Post Earnings on Wednesday - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025 - BioSpace

Feb 11, 2025
pulisher
Feb 10, 2025

Palatin (PTN) Q2 Earnings: Strategic Update & Pipeline ProgressKey Details Coming Feb 13 - StockTitan

Feb 10, 2025
pulisher
Feb 10, 2025

A closer look at PTN’s price-to-free cash flow ratio - US Post News

Feb 10, 2025
pulisher
Feb 10, 2025

Palatin Technologies’ (PTN) Buy Rating Reiterated at HC Wainwright - Defense World

Feb 10, 2025
pulisher
Feb 10, 2025

A Look at Palatin Technologies Inc (PTN) Shares in the Recent Past Indicates Growth - SETE News

Feb 10, 2025
pulisher
Feb 09, 2025

Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo - GlobeNewswire Inc.

Feb 09, 2025
pulisher
Feb 08, 2025

Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement - Nasdaq

Feb 08, 2025
pulisher
Feb 07, 2025

PTNPalatin Tech Latest Stock News & Market Updates - StockTitan

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin Technologies Inc [PTN] stock for 8,274 USD was sold by WILLS STEPHEN T - Knox Daily

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin Gains on New Offering - Baystreet.ca

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin Technologies prices 4.69M shares in direct offering - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin Announces $4.7 Million Registered Direct Offering and Co - GuruFocus.com

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin Technologies Announces $4.7 Mln Direct Offering - Nasdaq

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin concludes Phase II trial of combination therapy for obesity - Yahoo Finance

Feb 07, 2025
pulisher
Feb 07, 2025

Palatin finishes phase 2 trial in obesity treatment study By Investing.com - Investing.com Nigeria

Feb 07, 2025
pulisher
Feb 06, 2025

Palatin finishes phase 2 trial in obesity treatment study - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide - GuruFocus.com

Feb 06, 2025
pulisher
Feb 04, 2025

PTN’s price-to-sales ratio: A comparative analysis with its peers - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Palatin Technologies Inc (PTN) Stock: What the Analysts are Saying - The News Heater

Feb 04, 2025
pulisher
Feb 04, 2025

PTN’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Market Watch: Palatin Technologies Inc (PTN)’s Noteworthy Drop, Closing at 0.80 - The Dwinnex

Feb 04, 2025
pulisher
Jan 30, 2025

Palatin Technologies (NYSEAMERICAN:PTN) Earns “Buy” Rating from HC Wainwright - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Palatin gears up for obesity treatment trials in 2025 By Investing.com - Investing.com Canada

Jan 29, 2025

Palatin Technologies Inc. Azioni (PTN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$307.24
price up icon 0.61%
$76.55
price up icon 1.97%
$32.77
price up icon 0.28%
$20.79
price up icon 8.34%
$99.47
price up icon 2.06%
biotechnology ONC
$259.19
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):